Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6294)
All Articles published online
|
Publishing Process of This Article
|
May 15, 2021 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Guan MC, Ouyang W, Wang MD, Liang L, Li N, Fu TT, Shen F, Lau WY, Xu QR, Huang DS, Zhu H, Yang T. Biomarkers for hepatocellular carcinoma based on body fluids and feces. World J Gastrointest Oncol 2021; 13(5): 351-365 [PMID: 34040698 DOI: 10.4251/wjgo.v13.i5.351] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v13/i5/351.htm |
| Number | Citing Articles |
| 1 |
Ming-Cheng Guan, Ming-Da Wang, Wan-Yin Wang, Chao Li, Lan-Qing Yao, Hong Zhu, Tian Yang. Exosomes as mediators of tumor immune escape and immunotherapy in hepatocellular carcinoma. Liver Research 2022; 6(3): 132 doi: 10.1016/j.livres.2022.08.001
|
| 2 |
Cecilia Zertuche-Martínez, Juan Manuel Velázquez-Enríquez, Karina González-García, Rafael Baltiérrez-Hoyos, Gabriela Carrasco-Torres, Rebeca García-Román, Roberto Iván Romero-Díaz, José Luis Pérez-Hernández, Pablo Muriel, Saúl Villa-Treviño, Jaime Arellanes-Robledo, Verónica Rocío Vásquez-Garzón. Identification of ABCC3 and its isoforms as potential biomarker in hepatocellular carcinoma. Toxicology Mechanisms and Methods 2024; 34(4): 398 doi: 10.1080/15376516.2023.2294475
|
| 3 |
Andreja Abina, Tjaša Korošec, Uroš Puc, Mojca Jazbinšek, Aleksander Zidanšek. Urinary Metabolic Biomarker Profiling for Cancer Diagnosis by Terahertz Spectroscopy: Review and Perspective. Photonics 2023; 10(9): 1051 doi: 10.3390/photonics10091051
|
| 4 |
Sugan Panneerselvam, Cornelia Wilson, Prem Kumar, Dinu Abirami, Jayakrishna Pamarthi, Mettu Srinivas Reddy, Joy Varghese. Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options. Cell Adhesion & Migration 2023; 17(1): 1 doi: 10.1080/19336918.2023.2258539
|
| 5 |
Lekshmi R Nath, Maneesha Murali, Bhagyalakshmi Nair. Critical biomarkers of hepatocellular carcinoma in body fluids and gut microbiota. World Journal of Gastrointestinal Oncology 2021; 13(12): 2219-2222 doi: 10.4251/wjgo.v13.i12.2219
Abstract(481) |
Core Tip(641) |
Full Article(HTML)(1874)
|
Full Article (PDF)-1067K(200)
|
Full Article (Word)-307K(85)
|
Audio-102K(7)
|
Peer-Review Report-321K(80)
|
Answering Reviewers-219K(68)
|
Times Cited (0)
|
Total Visits (5857)
|
Open
|
| 6 |
Lan-Qing Yao, Zhong-Qi Fan, Ming-Da Wang, Yong-Kang Diao, Ting-Hao Chen, Yong-Yi Zeng, Zhong Chen, Xian-Ming Wang, Ya-Hao Zhou, Jie Li, Xin-Ping Fan, Ying-Jian Liang, Chao Li, Feng Shen, Guo-Yue Lv, Tian Yang. Prognostic Value of Serum α‐Fetoprotein Level as an Important Characteristic of Tumor Biology for Patients Undergoing Liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis. Annals of Surgical Oncology 2024; 31(2): 1219 doi: 10.1245/s10434-023-14525-w
|
| 7 |
Debayan Banik, Prasun Patra. Possibility of Liver Cancer Treatment By Nanoformulation of Phenolic
Phytochemicals. Current Nanomedicine 2022; 12(2): 108 doi: 10.2174/2468187312666220908094042
|
| 8 |
Wei Ouyang, Ming-Da Wang, Ming-Cheng Guan, Yong-Kang Diao, Li-Yang Sun, Nan-Ya Wang, Feng Shen, Hong Zhu, Tian Yang. Diagnostic performance comparisons of two commonly used multi-biomarker-based scores for detection of hepatocellular carcinoma in non-alcoholic fatty liver disease. iLIVER 2024; 3(2): 100098 doi: 10.1016/j.iliver.2024.100098
|
| 9 |
Maria Pallozzi, Natalia Di Tommaso, Valeria Maccauro, Francesco Santopaolo, Antonio Gasbarrini, Francesca Romana Ponziani, Maurizio Pompili. Non-Invasive Biomarkers for Immunotherapy in Patients with Hepatocellular Carcinoma: Current Knowledge and Future Perspectives. Cancers 2022; 14(19): 4631 doi: 10.3390/cancers14194631
|
| 10 |
Anas Elgenidy, Tareq M. Abubasheer, Ramez M. Odat, Mohamed G. Abdelrahim, Nada S. Jibril, Aya M. Ramadan, Lujain Ballut, Mohamed E. Haseeb, Abdelrahman Ragab, Almutasem M. Ismail, Ahmed M. Afifi, Benarad J. Mohamed, Prasun K. Jalal. Assessing the Predictive Accuracy of the aMAP Risk Score for Hepatocellular Carcinoma (HCC): Diagnostic Test Accuracy and Meta-analysis. Journal of Clinical and Experimental Hepatology 2025; 15(1): 102381 doi: 10.1016/j.jceh.2024.102381
|
| 11 |
S Pilar Zamora-León. Hepatocellular carcinoma biomarkers, an imminent need. World Journal of Gastrointestinal Oncology 2021; 13(11): 1847-1849 doi: 10.4251/wjgo.v13.i11.1847
|
| 12 |
Jingrui Dou, Wubulitalifu Dawuti, Xiangxiang Zheng, Rui Zhang, Jing Zhou, Renyong Lin, Guodong Lü. Urine fluorescence spectroscopy combined with machine learning for screening of hepatocellular carcinoma and liver cirrhosis. Photodiagnosis and Photodynamic Therapy 2022; 40: 103102 doi: 10.1016/j.pdpdt.2022.103102
|
| 13 |
Ming-Cheng Guan, Shi-Yu Zhang, Qian Ding, Na Li, Ting-Ting Fu, Gui-Xia Zhang, Qian-Qian He, Feng Shen, Tian Yang, Hong Zhu. The Performance of GALAD Score for Diagnosing Hepatocellular Carcinoma in Patients with Chronic Liver Diseases: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 2023; 12(3): 949 doi: 10.3390/jcm12030949
|